inHEART Models vs ElucidVivo A.3
AI Verdict
Choose inHEART Models if…
Choose inHEART Models if your primary focus is on optimizing the planning and execution of image-guided cardiac ablation procedures, especially for complex arrhythmias. This AI-driven software creates highly detailed 3D digital twin models of the heart from CT/MR images, enabling precise pre-procedural strategizing and seamless integration with electroanatomic mapping systems to potentially reduce procedure times and recurrence rates.
View inHEART Models →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if you require advanced, quantitative analysis of arterial plaque composition and stability from CT angiography to better stratify patients with atherosclerosis. This AI-powered system provides detailed visualization and measurement of plaque characteristics, including Lipid-Rich Necrotic Core, to aid in optimizing treatment decisions and assessing cardiovascular risk.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | inHEART Models | ElucidVivo A.3 |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Cloud-based | Cloud and on-premise secure deployment. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
inHEART ModelsinHEART Models offers a cloud-based platform with a straightforward interface and rapid model generation, enhancing pre-procedural planning efficiency. While it has some limitations with specific EAM system compatibility and offline access, its focus on interactive exploration and ease of use for its specialized application provides a slight advantage. ElucidVivo A.3 integrates well with PACS/EMR and follows typical clinical workflows, but lacks the explicit interactive and speed-focused user experience highlighted by Tool A.
Clinical Value
inHEART ModelsinHEART Models demonstrates significant potential to reduce VT procedure times by 60% and recurrence rates by 38% through highly detailed 3D cardiac models for ablation planning. These are direct, quantifiable impacts on patient outcomes and procedural efficiency for a complex intervention. ElucidVivo A.3 provides valuable, histology-validated quantitative plaque analysis and FFRct derivation, with a claimed 40% improvement in predictive accuracy for adverse neurologic events, but Tool A's claims are more directly tied to interventional success and efficiency.
Pricing & Value
inHEART ModelsBoth tools have undisclosed pricing, making a direct cost comparison impossible. However, inHEART Models has a newly established CMS reimbursement code (C9793) with a specified allowed amount, indicating a clear pathway for financial recovery for healthcare providers. This transparency in potential reimbursement provides a clearer understanding of its economic value proposition compared to ElucidVivo A.3, for which no such public reimbursement details were found.
Enterprise Readiness
inHEART ModelsinHEART Models is explicitly cloud-based and mentions SOC2 compliance, indicating a robust and scalable enterprise security and deployment posture. While its cloud deployment might necessitate initial compliance assessments, it reflects a modern infrastructure. ElucidVivo A.3 integrates with PACS/EMR, which is crucial for hospital workflows, but its deployment model is less explicitly defined, and it lacks specific security certifications like SOC2 in the provided information.
Innovation
inHEART ModelsinHEART Models' 'AI-driven digital twin of the heart' for personalized, image-guided cardiac ablation planning represents a cutting-edge application of AI in interventional cardiology, aiming to optimize complex surgical procedures. ElucidVivo A.3's histology-validated quantitative plaque analysis and FFRct derivation are also highly innovative for diagnostics and risk stratification. However, the comprehensive 'digital twin' concept for procedural planning offers a slightly more transformative approach to patient care.
Support & Docs
TieNeither tool provides extensive public information regarding dedicated customer support channels or comprehensive documentation. While inHEART Models has a publicly available coding guide, this alone is insufficient to declare a definitive winner in this dimension. Without more specific details on support offerings, it is difficult to distinguish between the two.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | inHEART Models | ElucidVivo A.3 |
|---|---|---|
| Name | inHEART Models | ElucidVivo A.3 |
| Company | inHEART | Elucid Bioimaging |
| Primary Application | Creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures. | Provides quantitative analysis of arterial plaque composition and stability from CT angiography, assisting in atherosclerosis patient stratification and optimizing treatment decisions. |
| Specialties | Cardiology, Radiology | Cardiology, Radiology, Vascular Surgery |
| Core Technology/Analysis | AI-driven digital twin of the heart, automated segmentation of CT and MR images. | AI-powered quantitative analysis of arterial plaque, objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images. |
| Input Imaging Modalities | CT/MR images | CT angiography |
| Key Output/Insights | Highly detailed, interactive 3D cardiac models; pre-procedural planning and optimization of treatment strategies. | Visualizes lesion-level plaque composition; provides 3D visualization of highlighted vessels; derives fractional flow reserve (FFRct). |
Videos
Demos, reviews, and walkthroughs featuring inHEART Models and ElucidVivo A.3.